Status:
COMPLETED
Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Therapeutic Plasma Exchange
Anticoagulant Therapy
Eligibility:
All Genders
Up to 24 years
Brief Summary
Despite its growing use across the world, and similar efficacy, filter-based therapeutic plasma exchange (TPE) continues to be used less often that centrifuge-based TPE. One of the reasons is that the...
Detailed Description
Studies that evaluate differences between filter-based vs. centrifuge based TPE are lacking. Heparin-based TPE is the most commonly used method of anti-coagulation when performing filter-based TPE. Ci...
Eligibility Criteria
Inclusion
- Patients who received therapeutic plasma exchange at Children's of Alabama between 2012 and 2019
Exclusion
- Patients that received TPE with concomitant extra-corporeal membrane oxygenation
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 4 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04351438
Start Date
January 1 2012
End Date
February 4 2024
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35233